Pacira Biosciences, Inc. (PCRX) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
"main_header": {
"sid": 1158866,
"name": "Pacira Biosciences, Inc.",
"stock_name": "Pacira Biosciences, Inc.",
"full_name": "Pacira Biosciences, Inc.",
"name_url": "stocks-analysis/pacira-biosciences-inc",
"exchange": 210,
"exchangecode": "NAS",
"country_id": 2,
"currency": "USD",
"cmp": "23.98",
"chg": -0.09,
"chgp": "-0.37%",
"dir": -1,
"prev_price": "24.07",
"mcapval": "1,201.50",
"mcap": "Small Cap",
"scripcode": "",
"symbol": "",
"ind_name": "Pharmaceuticals & Biotechnology",
"ind_code": 2305,
"indexname": "S&P 500",
"isin": "US6951271005",
"curr_date": "Dec 04",
"curr_time": "",
"bse_nse_vol": "1.15 M",
"exc_status": "Active",
"traded_date": "Dec 04, 2025",
"traded_date_str": "2025 12 04",
"score": "",
"scoreText": "",
"Live": 0,
"market_time": 0,
"is_blur": 1,
"is_blur_class": "blur-register-score-header",
"is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/pacira-biosciences-inc-1158866-210&utm_source=Spage_Header_Score",
"mojoone": {
"ismore": 0
}
},
"news": {
"results": [
{
"title": "Pacira Biosciences Forms Death Cross, Signaling Potential Bearish Trend",
"link": "https://www.marketsmojo.com/news/stocks-in-action/pacira-biosciences-forms-death-cross-signaling-potential-bearish-trend-3673956",
"imagepath": "https://i.marketsmojo.com/newsimg/2025/11/PaciraBioscienc_dealthcross_3673956.png",
"date": "2025-11-05 15:03:49",
"description": "Pacira Biosciences, Inc. has recently encountered a technical event known as a Death Cross, indicating potential market sentiment shifts. While the stock has gained 35.43% over the past year, recent performance shows a decline. Mixed technical indicators suggest caution as volatility may increase."
},
{
"title": "Pacira Biosciences, Inc. Experiences Evaluation Revision Amidst Market Dynamics and Performance Trends",
"link": "https://www.marketsmojo.com/news/stocks-in-action/pacira-biosciences-technical-trend-shifts-from-mildly-bullish-to-sideways-amid-stock-decline-3652048",
"imagepath": "https://i.marketsmojo.com/newsimg/2025/10/PaciraBioscienc_technicaldot_3652048.png",
"date": "2025-10-28 15:30:11",
"description": "Pacira Biosciences, Inc. has recently revised its evaluation amid changing market conditions. The company's stock price is currently $21.33, with a notable annual return of 25.32%, surpassing the S&P 500's 16.90%. However, its longer-term performance shows significant challenges compared to the broader market."
},
{
"title": "Is Pacira Biosciences, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-pacira-biosciences-inc-technically-bullish-or-bearish-3651342",
"imagepath": "",
"date": "2025-10-28 11:41:03",
"description": "As of 24 October 2025, the technical trend for Pacira Biosciences, Inc. has changed from mildly bullish to sideways. The current stance is neutral, with mixed signals across various indicators. The MACD shows a bearish signal on the weekly chart but is mildly bullish on the monthly chart. The Bollinger Bands and moving averages indicate bearish and mildly bullish trends, respectively. The KST is bullish weekly and mildly bullish monthly, while Dow Theory and OBV are both mildly bearish on a weekly and monthly basis.\n\nIn terms of performance, the stock has underperformed the S&P 500 over the past week and month, with returns of -4.94% and -16.55% compared to 1.92% and 2.32% for the index. However, it has outperformed the S&P 500 on a year-to-date and one-year basis, with returns of 15.39% and 27.73% versus 15.47% and 16.90%, respectively. Overall, the mixed signals suggest a cautious approach...."
},
{
"title": "Is Pacira Biosciences, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-pacira-biosciences-inc-technically-bullish-or-bearish-3647794",
"imagepath": "",
"date": "2025-10-27 11:52:09",
"description": "As of 24 October 2025, the technical trend for Pacira Biosciences, Inc. has changed from mildly bullish to sideways. The current stance is neutral, with mixed signals across different time frames. The weekly MACD is bearish, while the monthly MACD is mildly bullish. The Bollinger Bands indicate bearish conditions for both weekly and monthly periods. Moving averages show a mildly bullish trend on the daily timeframe, but the weekly and monthly Dow Theory and OBV readings are mildly bearish. \n\nIn terms of returns, the stock has underperformed the S&P 500 over the past week and month, with returns of -4.94% and -16.55% compared to the S&P 500's gains of 1.92% and 2.32%, respectively. However, it has outperformed the S&P 500 on a year-to-date and one-year basis...."
},
{
"title": "Is Pacira Biosciences, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-pacira-biosciences-inc-technically-bullish-or-bearish-3646330",
"imagepath": "",
"date": "2025-10-26 11:26:45",
"description": "As of 24 October 2025, the technical trend for Pacira Biosciences, Inc. has changed from mildly bullish to sideways. The current technical stance is neutral, with mixed signals across various indicators. The weekly MACD is bearish, while the monthly MACD is mildly bullish. The Bollinger Bands are bearish on both weekly and monthly time frames. Moving averages indicate a mildly bullish stance on the daily chart, but the weekly and monthly Dow Theory and OBV readings are mildly bearish. \n\nIn terms of performance, the stock has underperformed the S&P 500 over the past week and month, with returns of -4.94% and -16.55% compared to the S&P 500's 1.92% and 2.32%, respectively. However, it has outperformed the index on a year-to-date and one-year basis. Overall, the mixed indicators suggest caution in the current market environment...."
},
{
"title": "Pacira Biosciences, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics",
"link": "https://www.marketsmojo.com/news/stocks-in-action/pacira-biosciences-technical-trend-shifts-from-bullish-to-mildly-bullish-amid-stock-price-decline-3601141",
"imagepath": "https://i.marketsmojo.com/newsimg/2025/10/PaciraBioscienc_technicaldot_3601141.png",
"date": "2025-10-07 20:09:17",
"description": "Pacira Biosciences, Inc. has recently revised its evaluation amid changing market conditions. The stock is currently priced at $23.87, with a notable year-to-date return of 26.70%, outperforming the S&P 500. However, longer-term performance shows declines over three and five years compared to the index's growth."
},
{
"title": "Is Pacira Biosciences, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-pacira-biosciences-inc-technically-bullish-or-bearish-3599015",
"imagepath": "",
"date": "2025-10-07 12:16:12",
"description": "As of 3 October 2025, the technical trend for Pacira Biosciences, Inc. has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by the monthly MACD and KST indicators, both showing mildly bullish signals. However, the weekly MACD and Dow Theory indicate a mildly bearish stance, which tempers the overall bullish outlook. The daily moving averages are mildly bullish, while Bollinger Bands on the weekly timeframe are bearish, further contributing to mixed signals. \n\nIn terms of performance, Pacira has outperformed the S&P 500 on a year-to-date basis with a return of 26.70% compared to the S&P's 14.18%, and it has also significantly outperformed over the past year with a return of 44.54% versus 17.82%. However, the longer-term returns over 3 and 5 years are notably negative compared to the S&P 500...."
},
{
"title": "Is Pacira Biosciences, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-pacira-biosciences-inc-technically-bullish-or-bearish-3593746",
"imagepath": "",
"date": "2025-10-06 12:06:23",
"description": "As of 3 October 2025, the technical trend for Pacira Biosciences, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The daily moving averages also indicate a mildly bullish stance. However, the weekly Dow Theory and OBV are mildly bearish, which tempers the overall bullish sentiment. The stock has underperformed the S&P 500 over the past week and month, with returns of -1.58% and -8.61% compared to the S&P 500's gains of 1.09% and 4.15%, respectively. In contrast, the year-to-date and one-year returns are strong at 31.85% and 56.32%, significantly outperforming the S&P 500. Overall, the current technical stance is mildly bullish, supported by several indicators, but with caution due to some bearish signals...."
},
{
"title": "Is Pacira Biosciences, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-pacira-biosciences-inc-technically-bullish-or-bearish-3591817",
"imagepath": "",
"date": "2025-10-05 11:51:17",
"description": "As of 3 October 2025, the technical trend for Pacira Biosciences, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating a positive momentum. The daily moving averages also reflect a mildly bullish stance. However, the weekly Dow Theory shows a mildly bearish signal, which slightly tempers the overall outlook. \n\nIn terms of performance, the stock has underperformed the S&P 500 over the past week and month, with returns of -1.58% and -8.61% respectively, while it has outperformed over the year with a return of 56.32% compared to the S&P 500's 17.82%. Overall, the current technical stance is mildly bullish, driven by the positive signals from MACD and moving averages, despite some mixed indicators from Dow Theory and OBV...."
}
],
"total": 16,
"sid": "1158866",
"stock_news_url": "https://www.marketsmojo.com/news/pacira-biosciences-inc-1158866"
},
"announcements": "",
"corporate_actions": {
"msg": "No corporate action Found"
}
}

News and Views

Pacira Biosciences Forms Death Cross, Signaling Potential Bearish Trend

2025-11-05 15:03:49

Pacira Biosciences, Inc. has recently encountered a technical event known as a Death Cross, indicating potential market sentiment shifts. While the stock has gained 35.43% over the past year, recent performance shows a decline. Mixed technical indicators suggest caution as volatility may increase.

Pacira Biosciences, Inc. Experiences Evaluation Revision Amidst Market Dynamics and Performance Trends

2025-10-28 15:30:11

Pacira Biosciences, Inc. has recently revised its evaluation amid changing market conditions. The company's stock price is currently $21.33, with a notable annual return of 25.32%, surpassing the S&P 500's 16.90%. However, its longer-term performance shows significant challenges compared to the broader market.

Is Pacira Biosciences, Inc. technically bullish or bearish?

2025-10-28 11:41:03

As of 24 October 2025, the technical trend for Pacira Biosciences, Inc. has changed from mildly bullish to sideways. The current stance is neutral, with mixed signals across various indicators. The MACD shows a bearish signal on the weekly chart but is mildly bullish on the monthly chart. The Bollinger Bands and moving averages indicate bearish and mildly bullish trends, respectively. The KST is bullish weekly and mildly bullish monthly, while Dow Theory and OBV are both mildly bearish on a weekly and monthly basis. In terms of performance, the stock has underperformed the S&P 500 over the past week and month, with returns of -4.94% and -16.55% compared to 1.92% and 2.32% for the index. However, it has outperformed the S&P 500 on a year-to-date and one-year basis, with returns of 15.39% and 27.73% versus 15.47% and 16.90%, respectively. Overall, the mixed signals suggest a cautious approach....

Is Pacira Biosciences, Inc. technically bullish or bearish?

2025-10-27 11:52:09

As of 24 October 2025, the technical trend for Pacira Biosciences, Inc. has changed from mildly bullish to sideways. The current stance is neutral, with mixed signals across different time frames. The weekly MACD is bearish, while the monthly MACD is mildly bullish. The Bollinger Bands indicate bearish conditions for both weekly and monthly periods. Moving averages show a mildly bullish trend on the daily timeframe, but the weekly and monthly Dow Theory and OBV readings are mildly bearish. In terms of returns, the stock has underperformed the S&P 500 over the past week and month, with returns of -4.94% and -16.55% compared to the S&P 500's gains of 1.92% and 2.32%, respectively. However, it has outperformed the S&P 500 on a year-to-date and one-year basis....

Is Pacira Biosciences, Inc. technically bullish or bearish?

2025-10-26 11:26:45

As of 24 October 2025, the technical trend for Pacira Biosciences, Inc. has changed from mildly bullish to sideways. The current technical stance is neutral, with mixed signals across various indicators. The weekly MACD is bearish, while the monthly MACD is mildly bullish. The Bollinger Bands are bearish on both weekly and monthly time frames. Moving averages indicate a mildly bullish stance on the daily chart, but the weekly and monthly Dow Theory and OBV readings are mildly bearish. In terms of performance, the stock has underperformed the S&P 500 over the past week and month, with returns of -4.94% and -16.55% compared to the S&P 500's 1.92% and 2.32%, respectively. However, it has outperformed the index on a year-to-date and one-year basis. Overall, the mixed indicators suggest caution in the current market environment....

Pacira Biosciences, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics

2025-10-07 20:09:17

Pacira Biosciences, Inc. has recently revised its evaluation amid changing market conditions. The stock is currently priced at $23.87, with a notable year-to-date return of 26.70%, outperforming the S&P 500. However, longer-term performance shows declines over three and five years compared to the index's growth.

Is Pacira Biosciences, Inc. technically bullish or bearish?

2025-10-07 12:16:12

As of 3 October 2025, the technical trend for Pacira Biosciences, Inc. has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by the monthly MACD and KST indicators, both showing mildly bullish signals. However, the weekly MACD and Dow Theory indicate a mildly bearish stance, which tempers the overall bullish outlook. The daily moving averages are mildly bullish, while Bollinger Bands on the weekly timeframe are bearish, further contributing to mixed signals. In terms of performance, Pacira has outperformed the S&P 500 on a year-to-date basis with a return of 26.70% compared to the S&P's 14.18%, and it has also significantly outperformed over the past year with a return of 44.54% versus 17.82%. However, the longer-term returns over 3 and 5 years are notably negative compared to the S&P 500....

Is Pacira Biosciences, Inc. technically bullish or bearish?

2025-10-06 12:06:23

As of 3 October 2025, the technical trend for Pacira Biosciences, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The daily moving averages also indicate a mildly bullish stance. However, the weekly Dow Theory and OBV are mildly bearish, which tempers the overall bullish sentiment. The stock has underperformed the S&P 500 over the past week and month, with returns of -1.58% and -8.61% compared to the S&P 500's gains of 1.09% and 4.15%, respectively. In contrast, the year-to-date and one-year returns are strong at 31.85% and 56.32%, significantly outperforming the S&P 500. Overall, the current technical stance is mildly bullish, supported by several indicators, but with caution due to some bearish signals....

Is Pacira Biosciences, Inc. technically bullish or bearish?

2025-10-05 11:51:17

As of 3 October 2025, the technical trend for Pacira Biosciences, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating a positive momentum. The daily moving averages also reflect a mildly bullish stance. However, the weekly Dow Theory shows a mildly bearish signal, which slightly tempers the overall outlook. In terms of performance, the stock has underperformed the S&P 500 over the past week and month, with returns of -1.58% and -8.61% respectively, while it has outperformed over the year with a return of 56.32% compared to the S&P 500's 17.82%. Overall, the current technical stance is mildly bullish, driven by the positive signals from MACD and moving averages, despite some mixed indicators from Dow Theory and OBV....

View All News